Runaway Biology: A Call for Conscientious Genome Editing with CRISPR
By Søren Hough,
SFTP
| 01. 28. 2021
By 2018, it was clear that CRISPR had spun out of control. In the United States, one biotech company managed to bypass the Food and Drug Administration to get CRISPR-modified food onto people’s dinner plates. Not long after, a world-shaking report revealed that CRISPR had also been used without formal approval in China to edit the DNA of two baby girls, Lulu and Nana. As scientists and governments methodically deliberate on the best way to regulate CRISPR’s use in society, those seeking fame and fortune plow ahead heedless of the consequences. CRISPR, now a Nobel Prize-winning technology, is a permanent fixture in biological research and clinical medicine. We must take its dire ethical implications, from changing the food we eat to altering human evolution, more seriously.
Genetic Reductionism and CRISPR: Dire Bedfellows
When Drs. Jennifer Doudna and Emanuelle Charpentier were awarded the Nobel Prize in Chemistry for their work on CRISPR, the Nobel committee framed their discovery as a tool for rewriting the “code of life” DNA.https://www.nobelprize.org/prizes/chemistry/2020/press-release/." title>1 Describing DNA as the “code of life” is a common trope, and...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...